Article
Orphan Drug Exclusivity: A Lifeline for Rare Disease Patients
IQVIA Ark Patent Intelligence
Oct 22, 2024
Download

Discover the impact of Orphan Drug Exclusivity (ODE), a crucial protection that encourages innovation in rare disease treatments. ODE works independently or alongside other protections like Reference Product Exclusivity (RPE) and market protection, each with separate expiration dates. This exclusivity prevents any sponsor from producing the same drug for the same disease, even without using the original innovator's data.

Download the article to explore all the details.

Related solutions

Contact Us